$Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis$

Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis

Langerhans cell histiocytosis (LCH) is sometimes resistant to conventional chemotherapies, and treatment with 2-chlorodeoxyadenosine (2-CdA) is gaining importance as a salvage treatment for refractory or recurrent LCH. Secondary malignancies such as acute myelogenous leukemia and myelodysplastic syn...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of hematology 2013-06, Vol.97 (6), p.782-785
Hauptverfasser:	Suzuki, Daisuke, Kobayashi, Ryoji, Sano, Hirozumi, Kishimoto, Kenji, Yasuda, Kazue, Nakanishi, Masanori, Nagashima, Tetsuro, Kobayashi, Kunihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Biological and medical sciences Brain - pathology Brain Neoplasms - complications Brain Neoplasms - diagnosis Brain Neoplasms - drug therapy Cladribine - adverse effects Cladribine - therapeutic use Hematologic and hematopoietic diseases Hematology Hematopoietic Stem Cell Transplantation Histiocytosis, Langerhans-Cell - complications Histiocytosis, Langerhans-Cell - diagnosis Histiocytosis, Langerhans-Cell - drug therapy Humans Infant Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Magnetic Resonance Imaging Male Medical sciences Medicine Medicine & Public Health Myelodysplastic Syndromes - chemically induced Myelodysplastic Syndromes - diagnosis Myelodysplastic Syndromes - pathology Myelodysplastic Syndromes - therapy Oncology Original Article Other diseases. Hematologic involvement in other diseases Remission, Spontaneous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!